Sektor Summit Therapeutics Inc.

Aktien

A2QDFS

US86627T1088

SMMT

Biotechnologie

Realtime-Estimate 16:35:00 20.10.2026 Perf. 5 T Veränd. 1. Jan.
15.65 USD +0.51% Intraday Chart für Summit Therapeutics Inc. +0.06% -11.21%
Hauptkonkurrenten
% % 5 Tage Veränd. 1 Monat Veränd. 3 Monate % 1. Jan. Perf. 1 Jahr Perf. 3 Jahre Veränd. 5 Jahre Veränd. 10 Jahre Marktkap.($)
+0.51%+0.06%-8.11%+15.04%-11.21%-22.49%+739.46%+198.65%+31.05% 12.45 Mrd.
+1.52%-7.19%-8.44%+24.27%+61.63%+51.66%+69.99%+1.03% - 65.83 Mrd.
+1.79%+10.20%+13.74%+10.48%+16.07%+12.88%+87.50%-15.05%+237.22% 51.87 Mrd.
+6.30%+7.85%-10.71%+2.84%+8.12%+6.16%+70.97%+204.52%+5’211.86% 51.2 Mrd.
+1.10%+2.65%-0.85%+31.24%+18.71%+26.19%+45.15%+6.39%+259.57% 43.76 Mrd.
+1.79%+7.69%+2.80%+21.04%+23.73%+17.99%+127.54%+0.89%+1’039.83% 42.09 Mrd.
+6.11%+2.33%+0.04%+6.90%+142.11%+257.04%+589.45%+616.08% - 39.04 Mrd.
+2.16%+9.87%+10.48%+12.74%+14.98%+18.92%+59.70%+10.58%+163.35% 34 Mrd.
+3.84%-2.34%-5.57%+30.82%+59.19%+39.18%+8.57%-57.11% - 25.2 Mrd.
+2.12%+4.98%+14.73%+40.39%+27.92%+30.53%+25.63%-11.44%+124.31% 22.8 Mrd.
-0.03%-0.01%-9.18%-3.43%-6.51%-17.55%-2.10%-66.97% - 22.41 Mrd.
+1.62%-0.18%-20.15%-9.72%-44.48%-42.46%+285.25%+261.74%+586.71% 20.81 Mrd.
+1.87%+3.57%+1.19%+19.65%+12.46%+16.02%+175.53%+235.89%+1’943.51% 17.3 Mrd.
-5.62%-0.84%-0.42%-1.67%+177.32%+152.60%+367.34%+1’438.75%+717.19% 14.99 Mrd.
+1.56%+6.92%+11.20%+14.59%+45.17%+84.22%+201.42%+194.04%+441.99% 15.53 Mrd.
-0.99%-0.41%+0.10%+9.90%+25.22%+22.28%+69.91%-30.22%+84.77% 15.37 Mrd.
+1.55%+4.29%-2.02%-7.54% - - - - - 15.1 Mrd.
+3.33%+3.09%+10.48%+40.30%+54.53%+67.40%+66.25%-26.86%+271.39% 14.32 Mrd.
+3.54%+4.00%-5.57%-7.14%+19.33%-2.34%+545.07% - - 13.77 Mrd.
+4.51%+6.22%+2.96%+5.05%-4.20%-7.37%-23.00%-36.83%+106.03% 12.97 Mrd.
Durchschnitt +1.86%-0.01%-0.16%+12.79%+33.69%+37.41%+184.72%+162.45%+801.34% 27.54 Mrd.
Nach Marktkapitalisierung gewichteter Durchschnitt +2.24%+0.03%-0.38%+14.47%+35.57%+41.34%+152.99%+127.48%+1’117.97%
  1. Börse
  2. Aktien
  3. A2QDFS Aktie
  4. Sektor Summit Therapeutics Inc.